Teleflex_Global_Corporate_Brand_Logo_CMYK_Navy-White.png
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
May 01, 2024 06:30 ET | Teleflex Incorporated
Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine...
Global Urology Supplements Market
Global Urology Supplements Market Trends Analysis Report 2024-2030: Asia Pacific Emerges as Dominant Force, Multi-Ingredient Supplements Lead
April 30, 2024 05:36 ET | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Supplements Market Size, Share & Trends Analysis Report by Type (Multi-ingredient, Single Ingredient), Application (Urinary Tract...
22157.jpg
Global Portable Ultrasound Market Analysis Report 2024-2031: Use of Artificial Intelligence in Portable Ultrasound Devices and Emergence of Wearable Ultrasound Devices Gaining Momentum
April 18, 2024 07:23 ET | Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Portable Ultrasound Market by Product (POCUS, Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast...
TeleflexLogo.jpg
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
April 02, 2024 06:30 ET | Teleflex Incorporated
WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced...
Amber Theraputics Brand Mark BURNT ORANGE.png
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
February 27, 2024 09:00 ET | Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
Urinary Drainage Bags Market Anticipates Significant Surge, Estimated to Attain US$ 3.9 Billion by 2033, Report by Persistence Market Research
January 10, 2024 11:20 ET | Persistence Market Research
New York, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Urinary drainage bags are medical devices used for collecting and storing urine in patients with urinary incontinence, post-surgery, or other medical...
Aeroflow Health.png
Aeroflow Healthcare Rebrands to Aeroflow Health
January 09, 2024 12:00 ET | Aeroflow Health
Aeroflow Health reinforces its brand position as a personalized health partner with a longstanding commitment to positively impact health outcomes
Emergen logo.png
Ultrasonic Dissection Market Size Worth USD 20.42 Billion in 2032 | Emergen Research
December 28, 2023 08:03 ET | Emergen Research
Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The global ultrasonic dissection market size was USD 7.53 Billion in 2022 and is expected to register a revenue CAGR of 10.4% during the forecast period,...
Emergen logo.png
Global Electrosurgical Products Market Size to Reach USD 14.99 Billion in 2032 | Emergen Research
December 26, 2023 07:23 ET | Emergen Research
Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The global electrosurgical products market size was USD 8.90 Billion in 2022 and is expected to register a steady revenue CAGR of 5.3% during the...
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™
December 18, 2023 07:00 ET | Onconetix, Inc.
CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today announced the acquisition of Proteomedix AG, a private, commercial-stage...